China Approves Bayer’s Asundexian Blood Thinner

​China's drug regulator said on Monday it approved the blood thinner asundexian from Bayer XETR:BAYN, a potential boost for the German drugmaker in the world's second-largest pharmaceutical market as it moves to counter competition from generic medicines.Bayer is betting on asundexian to offset dec…